2019-2023 Latin America Automated Microbiology Market: A 7-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts for 100 Molecular, Identification, Susceptibility, Blood Culture, Urine Screening and Immunodiagnostic Tests

January 2019 | 550 pages | ID: 2708B240B96EN
Venture Planning Group

Abstracts

This new 7-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.

The survey is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the automated microbiology market during the next five years. The report examines key trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for 100 molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.

This comprehensive 7-country survey will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies.

Country Analyses

Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela

Specimen Types

• Urine
• Sterile Fluids: Blood, Serum, CSF
• Throat Swabs, Respiratory Secretions
• Genital Secretions
• Stool
• Abscess/Wound
• Sputum
• Saliva

Applications

• Microbial Identification
• Antibiotic Susceptibility
• Urine Screening
• Blood Cultures

Review of Major Automated Systems

Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers marketed by Abbott, Alifax, BD, Beckman Coulter/Danaher, Biolog, bioMerieux, Bio-Rad, Cepheid, Curetis, GenMark, Hologic, HTG, Labsystems, Qiagen, Roche, Siemens Healthineers, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh and other suppliers.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Technology Review

• Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market.
• Companies developing or marketing microbiology products, by individual test.

Competitive Assessments

Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

Opportunities and Strategic Recommendations

• Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years.
• Design criteria for decentralized testing products.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.

Contains over 550 pages and 96 tables

Contents

I. INTRODUCTION

II. AUTOMATED MICROBIOLOGY MARKET BUSINESS ENVIRONMENT

III. NEW PRODUCT DEVELOPMENT OPPORTUNITIES

IV. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

V. ALTERNATIVE MARKET PENETRATION STRATEGIES

VI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

VII. MARKET AND TECHNOLOGY OVERVIEW

A. INTRODUCTION
  1. MAJOR FACTORS AFFECTING MARKET PENETRATION FOR MICROBIOLOGY INSTRUMENTATION
  2. TRADITIONAL PRACTICES
  3. TECHNOLOGICAL CHALLENGES
  4. AUTOMATION: IMPACT ON THE MICROBIOLOGY LABORATORY AND THE PATIENT
B. Major Specimen Types
  1. URINE
  2. STERILE FLUIDS: BLOOD, SERUM, AND CSF
  3. THROAT SWABS AND RESPIRATORY SECRETIONS
  4. GENITAL SECRETIONS
  5. STOOL
  6. ABSCESS/WOUND
  7. SPUTUM
  8. SALIVA
C. Test Applications
  1. MICROBIAL IDENTIFICATION
  2. ANTIBIOTIC SUSCEPTIBILITY
  3. URINE SCREENING
    a. Photometry
    b. Bioluminescence
    c. Colorimetric Filtration
    d. Enzymatic Detection
    e. Optical Detection
  4. BLOOD CULTURES
D. Major Automated and Semi-automated Microbiology Systems
  1. MULTIPLE PURPOSE MICROBIOLOGY SYSTEMS
  2. SPECIALIZED MICROBIOLOGY SYSTEMS
  3. MOLECULAR DIAGNOSTIC SYSTEMS
  4. IMMUNODIAGNOSTIC SYSTEMS
E. Emerging Diagnostic Technologies
  1. MOLECULAR DIAGNOSTICS (AMPLIFICATION METHODS, SEQUENCING, MICROARRAYS/BIOCHIPS)
    a. DNA Sequencing
    b. DNA and RNA Probe Technologies
    c. Detection Technologies
    d. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
  2. MONOCLONAL ANTIBODIES
  3. IMMUNOASSAYS
  4. DIFFERENTIAL LIGHT SCATTERING
  5. INFORMATION TECHNOLOGY
  6. ARTIFICIAL INTELLIGENCE
  7. LIPOSOMES
  8. FLOW CYTOMETRY
  9. CHROMATOGRAPHY
  10. DIAGNOSTIC IMAGING
  11. GEL MICRODROPLETS
  12. OTHER

VIII. COUNTRY ANALYSES: SALES AND VOLUME FORECASTS FOR 100 MOLECULAR DIAGNOSTIC, MICROBIAL IDENTIFICATION, ANTIBIOTIC SUSCEPTIBILITY, BLOOD CULTURE, URINE SCREENING, AND IMMUNODIAGNOSTIC TESTS, SUPPLIER SHARES

Argentina
Brazil
Chile
Colombia
Mexico
Peru
Venezuela

IX. COMPETITIVE ASSESSMENTS

Abbott
Affymetrix/Thermo Fisher
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Biotest
CellMark Forensics/LabCorp
Cepheid
Decode
Diadexus
Diamedix
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
Hologic/Gen-Probe
ID Biomedical/GSK
Illumina
Kreatech/Leica
Li-Cor Biosciences
Lonza
Monogram Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics
Perkin Elmer/Caliper
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
SeraCare
Shimadzu
Siemens
Sierra Molecular
Takara Bio
Tecan
Wallac/PE
Wako

List Of Tables

LIST OF TABLES

Argentina Microbiology Specimen Volume Forecast by Type
Argentina Microbiology Test Volume Forecasts by Application
Argentina Microbiology Consumables Market Forecast by Application
Argentina Infectious Disease Test Volume Forecast by Assay
Argentina Infectious Disease Diagnostics Market Forecast by Test
Argentina Infectious Disease Blood Screening NAT Volume Forecast by Assay
Argentina Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
Brazil Microbiology Specimen Volume Forecast by Type
Brazil Microbiology Test Volume Forecasts by Application
Brazil Microbiology Consumables Market Forecast by Application
Brazil Infectious Disease Test Volume Forecast by Assay
Brazil Infectious Disease Diagnostics Market Forecast by Test
Brazil Infectious Disease Blood Screening NAT Volume Forecast by Assay
Brazil Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
Chile Microbiology Specimen Volume Forecast by Type
Chile Microbiology Test Volume Forecasts by Application
Chile Microbiology Consumables Market Forecast by Application
Chile Infectious Disease Test Volume Forecast by Assay
Chile Infectious Disease Diagnostics Market Forecast by Test
Chile Infectious Disease Blood Screening NAT Volume Forecast by Assay
Chile Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
Colombia Microbiology Specimen Volume Forecast by Type
Colombia Microbiology Test Volume Forecasts by Application
Colombia Microbiology Consumables Market Forecast by Application
Colombia Infectious Disease Test Volume Forecast by Assay
Colombia Infectious Disease Diagnostics Market Forecast by Test
Colombia Infectious Disease Blood Screening NAT Volume Forecast by Assay
Colombia Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
Mexico Microbiology Specimen Volume Forecast by Type
Mexico Microbiology Test Volume Forecasts by Application
Mexico Microbiology Consumables Market Forecast by Application
Mexico Infectious Disease Test Volume Forecast by Assay
Mexico Infectious Disease Diagnostics Market Forecast by Test
Mexico Infectious Disease Blood Screening NAT Volume Forecast by Assay
Mexico Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
Peru Microbiology Specimen Volume Forecast by Type
Peru Microbiology Test Volume Forecasts by Application
Peru Microbiology Consumables Market Forecast by Application
Peru Infectious Disease Test Volume Forecast by Assay
Peru Infectious Disease Diagnostics Market Forecast by Test
Peru Infectious Disease Blood Screening NAT Volume Forecast by Assay
Peru Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
Venezuela Microbiology Specimen Volume Forecast by Type
Venezuela Microbiology Test Volume Forecasts by Application
Venezuela Microbiology Consumables Market Forecast by Application
Venezuela Infectious Disease Test Volume Forecast by Assay
Venezuela Infectious Disease Diagnostics Market Forecast by Test
Venezuela Infectious Disease Blood Screening NAT Volume Forecast by Assay
Venezuela Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests